Partner, FB Rice (Australia)
Dr Patrick McManamny is a partner in the life sciences group of FB Rice. A large component of Patrick’s patent practice is due diligence and freedom-to-operate analysis, particularly in the field of biopharmaceuticals and processes for their manufacture. Patrick often works with our clients and counsel throughout the world to develop strategies for taking their products to market. He also regularly works with companies assessing third party technologies for acquisition or licensing.
Patrick also works with universities, research institutes and companies to develop global patent portfolios. His expertise includes biological therapies, such as antibodies, proteins, peptides and methods for their manufacture, stem cells, diagnostics, and drug-screening methods. Hehas experience in developing and managing complex patent portfolios, including developing strategies to coincide with regulatory filings.
Patrick holds a PhD in molecular biology and physiology and also served as in-house counsel at the Australian Stem Cell Centre (ASCC), which has provided valuable insight into the responsibilities of this role.
The focus will be on strategies that will help applicants secure useful and valuable IP protection in the US, Europe and China. Using real life examples to illustrate our point, the session will highlight the jurisdictional differences in patentable subject matter (for both biology type subject matter and software inventions); tactics for avoiding added matter […]